Trials / Unknown
UnknownNCT05640128
Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Renin Ratio for the Diagnosis of Primary Hyperaldosteronism
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
collaborative work within 2 hospitals at the CHU of Caen, at the CHRU of Lille, concerning the evaluation of the biological markers of primary hyperaldosteronism (PAH) with the dosage of aldosterone in LC -MS/MS, which is performed in both centers, with two different techniques. The main objective is to define the range of Aldosterone concentrations in LC MS/MS, of renin in an automated method, in populations of healthy volunteers, essential hypertensives, and hypertensives with primary hyperaldosteronism. , in order to establish a threshold for the screening of PAH by the RAR, and for the confirmation of PAH by a dynamic test with an Aldosterone threshold post salt load test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aldosterone in HPLC-MS/MS | Aldosterone in HPLC-MS/MS |
Timeline
- Start date
- 2018-01-02
- Primary completion
- 2023-01-02
- Completion
- 2024-01-01
- First posted
- 2022-12-07
- Last updated
- 2022-12-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05640128. Inclusion in this directory is not an endorsement.